No. |
DrugBank |
Drug (Description in trials) [Number of descriptions] |
KEGG DRUG * | KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 | Baclofen | [5] Aert, (r)-baclofen; Baclofen; Baclofen 20 mg; Baclofen ir; Rs-baclofen; | D00241 |
[2] GABBR1, GABBR2 |
[7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
[5] 2, 10, 13, 18, 149 |
2 | Botulinum toxin type A | [3] Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Clostridium botulinum toxin type a; | D00783 |
[1] SNAP25 |
[2] Insulin secretion, Synaptic vesicle cycle |
[13] 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
3 | Brivaracetam | [3] Brivaracetam; Brivaracetam 25 mg; Brivaracetam 50 mg; | D08879 |
[1] SV2A |
[1] ECM-receptor interaction |
[2] 149, 309 |
4 | Edonerpic | [1] Edonerpic; | - |
- |
- |
[1] 149 |
5 | Isoxaflutole | - | - |
- |
- |
[8] 5, 6, 13, 18, 81, 113, 149, 299 |
6 | Lacosamide | [1] Lacosamide; | D07299 |
[2] SCN3A, SCN9A |
[1] Taste transduction |
[3] 2, 46, 149 |
7 | Padsevonil | [1] Padsevonil; | - |
- |
- |
[1] 149 |
8 | Sodium oxybate | [1] Sodium oxybate; | D05866 |
- |
- |
[3] 6, 120, 149 |
9 | Triheptanoin | [4] Triheptanoin; Triheptanoin 1g/kg/day; Triheptanoin oil; Ux007 (triheptanoin); | D11465 |
- |
- |
[10] 2, 8, 120, 149, 156, 248, 256, 257, 317, 324 |
10 | gamma-Hydroxybutyric acid | - | - |
- |
- |
[3] 6, 120, 149 |